315 related articles for article (PubMed ID: 16685687)
1. Minor depression and brain perfusion images in Parkinson's disease.
Matsui H; Nishinaka K; Oda M; Komatsu K; Kubori T; Udaka F
Mov Disord; 2006 Aug; 21(8):1169-74. PubMed ID: 16685687
[TBL] [Abstract][Full Text] [Related]
2. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
[TBL] [Abstract][Full Text] [Related]
4. Neuroanatomical correlates of depression and apathy in Parkinson's disease: magnetic resonance imaging studies.
Kostić VS; Filippi M
J Neurol Sci; 2011 Nov; 310(1-2):61-3. PubMed ID: 21684552
[TBL] [Abstract][Full Text] [Related]
5. Object naming and action-verb generation in Parkinson's disease: a fMRI study.
Péran P; Cardebat D; Cherubini A; Piras F; Luccichenti G; Peppe A; Caltagirone C; Rascol O; Démonet JF; Sabatini U
Cortex; 2009 Sep; 45(8):960-71. PubMed ID: 19368905
[TBL] [Abstract][Full Text] [Related]
6. Amnestic mild cognitive impairment in Parkinson's disease: a brain perfusion SPECT study.
Nobili F; Abbruzzese G; Morbelli S; Marchese R; Girtler N; Dessi B; Brugnolo A; Canepa C; Drosos GC; Sambuceti G; Rodriguez G
Mov Disord; 2009 Feb; 24(3):414-21. PubMed ID: 19235928
[TBL] [Abstract][Full Text] [Related]
7. Correlations between gray matter reductions and cognitive deficits in dementia with Lewy Bodies and Parkinson's disease with dementia.
Sanchez-Castaneda C; Rene R; Ramirez-Ruiz B; Campdelacreu J; Gascon J; Falcon C; Calopa M; Jauma S; Juncadella M; Junque C
Mov Disord; 2009 Sep; 24(12):1740-6. PubMed ID: 19569130
[TBL] [Abstract][Full Text] [Related]
8. Potential role of high-field MRI for studies in Parkinson's disease.
Schuff N
Mov Disord; 2009; 24 Suppl 2():S684-90. PubMed ID: 19877239
[TBL] [Abstract][Full Text] [Related]
9. Olfactory-induced brain activity in Parkinson's disease relates to the expression of event-related potentials: a functional magnetic resonance imaging study.
Welge-Lüssen A; Wattendorf E; Schwerdtfeger U; Fuhr P; Bilecen D; Hummel T; Westermann B
Neuroscience; 2009 Aug; 162(2):537-43. PubMed ID: 19401224
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism.
Plaha P; Ben-Shlomo Y; Patel NK; Gill SS
Brain; 2006 Jul; 129(Pt 7):1732-47. PubMed ID: 16720681
[TBL] [Abstract][Full Text] [Related]
11. Depression in Parkinson's disease: convergence from voxel-based morphometry and functional magnetic resonance imaging in the limbic thalamus.
Cardoso EF; Maia FM; Fregni F; Myczkowski ML; Melo LM; Sato JR; Marcolin MA; Rigonatti SP; Cruz AC; Barbosa ER; Amaro E
Neuroimage; 2009 Aug; 47(2):467-72. PubMed ID: 19398020
[TBL] [Abstract][Full Text] [Related]
12. [Parkinson's disease and Alzheimer's disease--similarities in magnetic resonance imaging parameters and their possible explanation].
Ebmeier KP; Besson JA; Cherryman G; Smith F
Z Gerontol; 1988; 21(3):142-5. PubMed ID: 3407284
[TBL] [Abstract][Full Text] [Related]
13. The relationship between slowing EEGs and the progression of Parkinson's disease.
Morita A; Kamei S; Serizawa K; Mizutani T
J Clin Neurophysiol; 2009 Dec; 26(6):426-9. PubMed ID: 19952568
[TBL] [Abstract][Full Text] [Related]
14. Levodopa-sensitive, dynamic changes in effective connectivity during simultaneous movements in Parkinson's disease.
Palmer SJ; Eigenraam L; Hoque T; McCaig RG; Troiano A; McKeown MJ
Neuroscience; 2009 Jan; 158(2):693-704. PubMed ID: 18722512
[TBL] [Abstract][Full Text] [Related]
15. Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease.
Lemke MR; Brecht HM; Koester J; Reichmann H
J Neurol Sci; 2006 Oct; 248(1-2):266-70. PubMed ID: 16814808
[TBL] [Abstract][Full Text] [Related]
16. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A
Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857
[TBL] [Abstract][Full Text] [Related]
17. Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process?
Pålhagen SE; Carlsson M; Curman E; Wålinder J; Granérus AK
Acta Neurol Scand; 2008 May; 117(5):295-304. PubMed ID: 18279483
[TBL] [Abstract][Full Text] [Related]
18. Functional abnormalities in the primary orofacial sensorimotor cortex during speech in Parkinson's disease.
Rektorova I; Barrett J; Mikl M; Rektor I; Paus T
Mov Disord; 2007 Oct; 22(14):2043-51. PubMed ID: 17683056
[TBL] [Abstract][Full Text] [Related]
19. Structural brain correlates of verbal fluency in Parkinson's disease.
Pereira JB; Junqué C; Martí MJ; Ramirez-Ruiz B; Bartrés-Faz D; Tolosa E
Neuroreport; 2009 May; 20(8):741-4. PubMed ID: 19349926
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance relaxometry in Parkinson's disease.
Mondino F; Filippi P; Magliola U; Duca S
Neurol Sci; 2002 Sep; 23 Suppl 2():S87-8. PubMed ID: 12548357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
